 |
Epoprostenol |
|---|---|
| Trade Name | Cycloprostin |
| Orphan Indication | Replacement of heparin in patients requiring hemodialysis and who are at increased risk of hemorrhage |
| USA Market Approval | USA |
| USA Designation Date | 1984-10-29 00:00:00 |
| Sponsor | Upjohn Company;301 Henrietta Street;Kalamazoo, Michigan, 49001 |
